Taken together, PTHrP enhances CCL2 expression in osteoblasts, signifying the role of prostate cancer cell-derived PTHrP in bone metastasis, likely via enhanced CCL2 expression (6, 79, 80). This evidence concerns the gene PTHLH and prostate carcinoma.